Global Montelukast Sodium Sales Market Report 2020

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The major raw material for montelukast sodium is 7-chloroquinaldine, isophthalaldehyde, etc. On the global market, supply of raw materials is relatively full. Fluctuations in the price of the upstream product will impact on the production cost of montelukast sodium industry.

Market Analysis and Insights: Global Montelukast Sodium Market
The global Montelukast Sodium market size is projected to reach US$ 509.8 million by 2026, from US$ 271.1 million in 2020, at a CAGR of 11.1% during 2021-2026.

Global Montelukast Sodium Scope and Market Size
The global Montelukast Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Montelukast Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Montelukast Sodium market is segmented into
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline

Segment by Application, the Montelukast Sodium market is segmented into
Tablets
Chewable Tablet
Oral Solution

The Montelukast Sodium market is analysed and market size information is provided by regions (countries). Segment by Application, the Montelukast Sodium market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Montelukast Sodium Market Share Analysis
Montelukast Sodium market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Montelukast Sodium business, the date to enter into the Montelukast Sodium market, Montelukast Sodium product introduction, recent developments, etc.

The major vendors covered:
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Groups
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical